
Weighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.
Eydie G. Miller-Ellis, MD, is a professor of clinical ophthalmology and director of the glaucoma service at the Scheie Eye Institute, Perelman School of Medicine at the University of Pennsylvania in Philadelphia.
Weighing the benefits and trade-offs of preserved versus preservative-free glaucoma treatments is key to optimizing long-term patient care.